These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9888868)

  • 21. C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: the PRIME Study.
    Luc G; Bard JM; Juhan-Vague I; Ferrieres J; Evans A; Amouyel P; Arveiler D; Fruchart JC; Ducimetiere P;
    Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1255-61. PubMed ID: 12775578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibrinogen and coronary heart disease: test of causality by 'Mendelian randomization'.
    Keavney B; Danesh J; Parish S; Palmer A; Clark S; Youngman L; Delépine M; Lathrop M; Peto R; Collins R
    Int J Epidemiol; 2006 Aug; 35(4):935-43. PubMed ID: 16870675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemostatic variables in the prediction of coronary risk: results of the 8 year follow-up of healthy men in the Münster Heart Study (PROCAM). Prospective Cardiovascular Münster Study.
    Assmann G; Cullen P; Heinrich J; Schulte H
    Isr J Med Sci; 1996 Jun; 32(6):364-70. PubMed ID: 8682642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Marital stress worsens prognosis in women with coronary heart disease: The Stockholm Female Coronary Risk Study.
    Orth-Gomér K; Wamala SP; Horsten M; Schenck-Gustafsson K; Schneiderman N; Mittleman MA
    JAMA; 2000 Dec; 284(23):3008-14. PubMed ID: 11122587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial.
    Schaefer EJ; Lamon-Fava S; Jenner JL; McNamara JR; Ordovas JM; Davis CE; Abolafia JM; Lippel K; Levy RI
    JAMA; 1994 Apr; 271(13):999-1003. PubMed ID: 8139085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study.
    Pradhan AD; Manson JE; Rossouw JE; Siscovick DS; Mouton CP; Rifai N; Wallace RB; Jackson RD; Pettinger MB; Ridker PM
    JAMA; 2002 Aug; 288(8):980-7. PubMed ID: 12190368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma cystatin-C and development of coronary heart disease: The PRIME Study.
    Luc G; Bard JM; Lesueur C; Arveiler D; Evans A; Amouyel P; Ferrieres J; Juhan-Vague I; Fruchart JC; Ducimetiere P;
    Atherosclerosis; 2006 Apr; 185(2):375-80. PubMed ID: 16046222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines.
    Shai I; Rimm EB; Hankinson SE; Curhan G; Manson JE; Rifai N; Stampfer MJ; Ma J
    Circulation; 2004 Nov; 110(18):2824-30. PubMed ID: 15492318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular risk parameters in men with ankylosing spondylitis in comparison with non-inflammatory control subjects: relevance of systemic inflammation.
    Divecha H; Sattar N; Rumley A; Cherry L; Lowe GD; Sturrock R
    Clin Sci (Lond); 2005 Aug; 109(2):171-6. PubMed ID: 15801904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma fibrinogen explains much of the difference in risk of coronary heart disease between France and Northern Ireland. The PRIME study.
    Scarabin PY; Arveiler D; Amouyel P; Dos Santos C; Evans A; Luc G; Ferrières J; Juhan-Vague I;
    Atherosclerosis; 2003 Jan; 166(1):103-9. PubMed ID: 12482556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma fibrinogen of black South Africans: the BRISK study.
    Vorster HH; Jerling JC; Steyn K; Badenhorst CJ; Slazus W; Venter CS; Jooste PL; Bourne LT
    Public Health Nutr; 1998 Sep; 1(3):169-76. PubMed ID: 10933414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum fatty acids and the risk of coronary heart disease.
    Simon JA; Hodgkins ML; Browner WS; Neuhaus JM; Bernert JT; Hulley SB
    Am J Epidemiol; 1995 Sep; 142(5):469-76. PubMed ID: 7677125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coronary heart disease risk factors and menopause: a study in 1980 Tehranian women, the Tehran Lipid and Glucose Study.
    Azizi F; Ainy E
    Climacteric; 2003 Dec; 6(4):330-6. PubMed ID: 15006254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pre-existence of an acute coronary event predicts differences in biological parameters and clinical evolution among patients with longstanding stable angina.
    Sposito AC; Lemos PA; Maranhão RC; Mansur AP; Cesar LA; Ramires JA
    Int J Cardiol; 2003 Oct; 91(2-3):193-200. PubMed ID: 14559130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.
    Downs JR; Clearfield M; Weis S; Whitney E; Shapiro DR; Beere PA; Langendorfer A; Stein EA; Kruyer W; Gotto AM
    JAMA; 1998 May; 279(20):1615-22. PubMed ID: 9613910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The G-455A polymorphism of the fibrinogen Bbeta-gene relates to plasma fibrinogen in male cases, but does not interact with environmental factors in causing myocardial infarction in either men or women.
    Leander K; Wiman B; Hallqvist J; Falk G; De Faire U
    J Intern Med; 2002 Oct; 252(4):332-41. PubMed ID: 12366606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-6 and the risk of future cardiovascular events in patients with angina pectoris and/or healed myocardial infarction.
    Fisman EZ; Benderly M; Esper RJ; Behar S; Boyko V; Adler Y; Tanne D; Matas Z; Tenenbaum A
    Am J Cardiol; 2006 Jul; 98(1):14-8. PubMed ID: 16784912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipoprotein lipase D9N, N291S and S447X polymorphisms: their influence on premature coronary heart disease and plasma lipids.
    van Bockxmeer FM; Liu Q; Mamotte C; Burke V; Taylor R
    Atherosclerosis; 2001 Jul; 157(1):123-9. PubMed ID: 11427211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum parathyroid hormone levels predict coronary heart disease: the Tromsø Study.
    Kamycheva E; Sundsfjord J; Jorde R
    Eur J Cardiovasc Prev Rehabil; 2004 Feb; 11(1):69-74. PubMed ID: 15167209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma fibrinogen levels are associated with a strong family history of myocardial infarction.
    Robinson DM; Schwahn C; Alte D; John U; Felix SB; Völzke H
    Blood Coagul Fibrinolysis; 2004 Sep; 15(6):497-502. PubMed ID: 15311159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.